March 10, 2020 09:47 AM EDTUpdated March 11, 02:02 PM

J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO

GenScript, the low-profile owner of CAR-T dark horse Nanjing Legend Biotech, is hatching a plan to spin out its famous subsidiary and shoot for a …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

J&J's fa­vorite CAR-T de­vel­op­er, cur­rent­ly owned by a Chi­nese CRO, is lay­ing the ground­work for US IPO